Thymosin Beta-10 in Breast Cancer
Author Information
Author(s): S Verghese-Nikolakakil, N Apostolikas, E Livanioul, DS Ithakissios, GP Evangelatos
Primary Institution: Institute of Radioisotopes and Radiodiagnostic Products, NCSR 'Demokritos'
Hypothesis
The study investigates the expression of thymosin beta-10 in human breast cancer tissues.
Conclusion
Thymosin beta-10 is highly expressed in malignant breast tissue and its expression increases with the grade of cancer.
Supporting Evidence
- Thymosin beta-10 was detected mainly in malignant breast tissue.
- The intensity of staining in cancerous cells increased with the grade of lesions.
- Normal tissue showed very weak staining for thymosin beta-10.
Takeaway
This study found that a protein called thymosin beta-10 is more present in breast cancer cells than in normal cells, which might help doctors diagnose cancer better.
Methodology
The study used immunohistochemistry to stain breast tissue samples with a specific antibody for thymosin beta-10.
Limitations
The small number of patients limits the ability to draw firm conclusions.
Participant Demographics
Female patients aged between 24 and 76 years.
Want to read the original?
Access the complete publication on the publisher's website